Login to Your Account



Deals And M&A NEWS

Macrogenics Inc. shares climbed 16.7 percent on Wednesday as Janssen Biotech Inc. extended its collaboration with the company, agreeing to pay $75 million up front for a global license to MGD015.

HONG KONG – In a move to improve its drug manufacturing, research and development capacity as well as to strengthen its international presence, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. made an offer to acquire a 96 percent stake in Gland Pharma Ltd.

SHANGHAI – In China's evolving regulatory and pricing environment, Sciclone Pharmaceuticals Inc., has managed to keep growing its bottom line with lead drug Zadaxin (thymalfasin), an imported drug manufactured in Italy for the treatment of hepatitis B, hepatitis C, certain cancers and as a vaccine adjuvant.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: